Parents Told Newborn's Noises Are 'Normal'—Then Comes Devastating Diagnosis
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Two parents from Toronto, Canada, were excited to bring their newborn daughter home from hospital, but just a few weeks later, they were rushing her to the emergency room.
Stephanie Mulhall-Atkinson and Justin Atkinson (@warriergirlsloane) shared their story on Instagram, where they said their daughter, Sloane, had been making a soft but persistent grunting noise.
Stephanie, 37, told Newsweek that the couple brought this to the attention of doctors, nurses and their pediatrician.
From left: Justin Atkinson holds baby Sloane wrapped in hospital bedsheets.
From left: Justin Atkinson holds baby Sloane wrapped in hospital bedsheets.
@warriorgirlsloane
"We were told that she was just moaning and that it was normal and that was just her normal baby noises, which we now know is not true," Stephanie said.
The grunting, the couple now know, was not harmless. It was a sign that Sloane was struggling to breathe, and her body was working overtime to survive.
The parents said several symptoms were overlooked. "She would mostly grunt when she was sleeping and being held," Stephanie added. "We also noticed that she was sweaty … and was happier when she was laying by herself."
When Sloane stopped eating one morning and had a faint ring of blue around her mouth—usually a sign of cyanosis where oxygen levels are low—the parents took her to the ER.
At The Hospital for Sick Children (SickKids), doctors told Stephanie and Justin that Sloane's grunting meant their baby was in distress.
"We were shocked and angry," Justin said. "Everything quickly declined from there."
Within hours, Sloane was in the emergency operating room, surrounded by more than 20 specialists.
A cardiology fellow performed an echocardiogram that revealed her heart was barely functioning.
Then came the devastating diagnosis: dilated cardiomyopathy, a condition where the heart becomes enlarged and weakened, leaving it unable to pump blood effectively.
A week later, doctors confirmed she was in end-stage heart failure, and a transplant would be Sloane's only chance at survival.
"You can't even comprehend what's happening," Stephanie said. "To hear that your tiny perfect 'healthy' baby needs a heart transplant to survive is truly beyond words."
Sloane has now spent seven months in hospital. The family relocated from Vancouver to Toronto's SickKids Hospital, one of only three centers in Canada equipped to implant a Ventricular Assist Device (VAD). This now keeps Sloane alive as she waits for a donor heart.
Sloane has now been on the transplant list for six months. The average wait time in Canada is six to 12 months.
"We're just living life as 'normally' as possible until then," Stephanie said. "She's the happiest, funniest girl. Each day, we focus on her development and keeping her growing and getting strong, so that her recovery posttransplant goes smoothly! We can't wait to be able to take her home."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
an hour ago
- Newsweek
Map Shows States Hit Hardest by Measles Outbreak as Cases Break Record
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The United States has already seen more measles cases in 2025 than in any year since the virus was declared eliminated nationally in 2000, with 1,277 confirmed cases as of Saturday, according to the Johns Hopkins University Center for Outbreak Response Innovation. Dr. Neil Maniar, director of Northeastern University's public health program, told Newsweek that this news is "very concerning" and warned there could be future outbreaks over the coming years if trends surrounding vaccinations do not reverse. Here is a look at which states have seen the highest number of cases this year. Why It Matters The 1,277 figure outpaces the 1,274 cases reported during the 2019 peak, only about halfway through the year. Measles was declared eliminated in the U.S. by 2000 due to the MMR (measles, mumps, rubella) vaccine approved in 1971. The vaccine, which is easily accessible in the country, has been touted by public health experts as a safe and effective way to mitigate the spread of the virus and prevent serious illness. However, a recent rise in vaccine skepticism associated with the COVID-19 pandemic has left a growing number of children vulnerable to infection amid new outbreaks of the virus, which can cause serious health complications or even death. What to Know Most measles cases this year stem from a large outbreak originating in West Texas' Gaines County, home to a close-knit, undervaccinated Mennonite community. There have been 155 hospitalizations across the country and three confirmed deaths so far this year. Experts attribute the current surge to declining childhood vaccination rates, a trend that worsened after the pandemic due to increased vaccine hesitancy, though most public health officials say the vaccination remains safe despite concerns—and misinformation that has spread. In Texas, there have been 790 cases of measles so far in 2025, according to data from Johns Hopkins. Neighboring state New Mexico places second with 95 cases, while Kansas has seen 83 confirmed measles cases this year. Ohio has seen 35 cases this year, while North Dakota rounds out the five states with the most cases at 34 confirmed instances of the virus. Maniar said the increased number of cases is unsurprising given the rise in anti-vaccine sentiment over recent years. There are several things that must happen to prevent future outbreaks, including improvements to the infrastructure to ensure all communities have access to vaccines, as well as efforts to educate people about and restore trust in vaccines, he said. "Measles is one of the most infectious diseases out there. Even though we have highly effective vaccine, we see many areas across the country fall below that threshold of herd immunity, 95 percent threshold," Maniar said. "I think one can anticipate that we'll see this types of outbreaks." Dr. Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, told Newsweek the rise in cases is an international phenomenon tied to both anti-vaccine sentiment, as well as people believing that measles is no longer a problem. "We have a lot of work to do," he said. "How do we message to those who refuse to vaccinate or get vaccinated? This is a real problem. We have many more questions than we have answers." He pointed to Canada—where there have been more than 3,500 new cases this year—as an example of how rising measles cases is a global challenge. A Department of Health and Human Services (HHS) spokesperson told Newsweek that Secretary Robert F. Kennedy Jr. has given clear guidance that vaccines are the most effective way to prevent measles. The spokesperson noted that HHS recognizes that some individuals and communities may choose not to vaccine and that HHS remains committed to supporting everyone in avoiding hospitalization and serious complications from measles. A sign pointing to measles testing is seen on February 27 in Seminole, Texas. A sign pointing to measles testing is seen on February 27 in Seminole, Are Measles Symptoms? Measles is a highly contagious, airborne virus that can cause "serious health complications," particularly for children who are younger than five years old, according to the U.S. Centers for Disease Control and Prevention (CDC). The CDC notes that a single dose of the MMR vaccine is about 93 percent effective, while two doses of the vaccine is about 97 percent effective at preventing measles. Children are advised to get the first dose between 12 and 15 months of age, and the second dose when they are between 4 and 6 years old. What People Are Saying U.S. Centers for Disease Control and Prevention emphasized prevention: "The best way to protect against measles is to get the measles, mumps, and rubella (MMR) vaccine. Children may get the measles, mumps, rubella, and varicella (MMRV) vaccine instead, which protects against chickenpox too." Dr. Neil Maniar told Newsweek: "This is a disease we had eradicated in this country. We should all take notice of the fact that we are seeing numbers we haven't seen since the early 1990s. This is concerning, but this is solvable. We eradicated measles once, so we can do it again. But it's going to require everyone to play a role. And it's going to require folks to make sure they get vaccinated if they haven't. We have very safe very effective vaccine. There's no reason anyone should be getting measles right now." What Happens Next? Public health authorities have increased vaccination campaigns and are closely monitoring outbreaks and international travel, which has contributed to transmission. The trajectory of the outbreak will depend on vaccination uptake and rapid response to new cases. The CDC continues to issue guidance and risk assessments to inform ongoing efforts.
Newsweek
an hour ago
- Newsweek
RFK Jr. Faces New Lawsuit from Top Medical Groups: 'Existential Threat'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A coalition of six medical organizations—including the American Academy of Pediatrics, American College of Physicians and Infectious Diseases Society of America—filed a federal lawsuit Monday against Health and Human Services Secretary Robert F. Kennedy Jr. in the District of Massachusetts. "This administration is an existential threat to vaccination in America, and those in charge are only just getting started," said Richard H. Hughes IV, lead counsel for the plaintiffs. "The professional associations for pediatricians, internal medicine physicians, infectious disease physicians, high-risk pregnancy physicians, and public health professionals will not stand idly by as our system of prevention is dismantled. This ends now." The suit challenges Kennedy's unilateral decision to revoke COVID-19 vaccine recommendations for children and pregnant people, calling the move an attack on evidence-based medicine and public health. The plaintiffs argue that Kennedy acted arbitrarily by dismissing 17 members of the CDC's Advisory Committee on Immunization Practices and replacing them with individuals known for anti-vaccine views. The lawsuit seeks preliminary and permanent injunctions to block the policy changes, as well as a court declaration deeming them unlawful. This is a breaking news story. Updates to follow.
Newsweek
3 hours ago
- Newsweek
Evolution: Single Mutation May Explain Humans' Higher Cancer Risk
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A newly discovered genetic mutation unique to humans may help explain why we are significantly more vulnerable to cancer than our closest evolutionary relatives. Researchers at the University of California, Davis, identified a single amino acid change in a key immune system protein—dubbed "Fas Ligand" (FasL)—that appears to give solid tumors in humans a biological loophole, allowing them to evade immune attack. The same vulnerability is not present in chimpanzees or other non-human primates, the team report. "The evolutionary mutation in FasL may have contributed to the larger brain size in humans," said lead author Jogender Tushir-Singh, an associate professor of medical microbiology and immunology at UC Davis. "But in the context of cancer, it was an unfavorable tradeoff because the mutation gives certain tumors a way to disarm parts of our immune system." 3d rendering DNA and flying molecule cells on microscope background, Depth Of Field. 3d rendering DNA and flying molecule cells on microscope background, Depth Of Field. mustafaU Fas Ligand plays a critical role in the immune system's ability to kill cancer cells. Found on the surface of immune cells—including the CAR-T cells used in cutting-edge cancer therapies—FasL triggers a process known as apoptosis, or programmed cell death, in target cells. The team's investigation reveals that in humans, a single amino acid substitution—from proline to serine at position 153—renders FasL vulnerable to plasmin, an enzyme frequently elevated in aggressive solid tumors like ovarian, colon and triple-negative breast cancers. When plasmin cleaves FasL, it effectively disarms one of the immune system's key cancer-fighting tools, allowing tumors to grow and spread despite an active immune response. This mechanism may help explain why immunotherapies like CAR-T cells, which have revolutionized treatment for blood cancers, often struggle to achieve similar success with solid tumors. Solid tumors create a hostile microenvironment that actively neutralizes FasL using plasmin, the researchers explained. In blood cancers, where plasmin isn't a major factor, immune cells retain more of their killing power. The team also found that blocking plasmin or modifying FasL to resist cleavage can restore its tumor-killing ability, potentially improving the effectiveness of immunotherapy for solid tumors. These findings open up new possibilities for enhancing immune-based treatments using plasmin inhibitors or engineered antibodies that shield FasL from degradation. This could help us overcome one of the key reasons why immune therapies work well in leukemia or lymphoma but have limited success in solid tumors. While the mutation in FasL may have weakened immune defenses against cancer, the researchers speculate that it may also have been tied to benefits during human evolution—possibly linked to the development of a larger brain. Such evolutionary tradeoffs, the study suggests, might help explain why cancer rates are significantly higher in humans compared to chimpanzees, despite our shared genetic ancestry. "There is a lot that we do not know and can still learn from primates and apply to improve human cancer immunotherapies," said Tushir-Singh. "Regardless, this is a major step toward personalizing and enhancing immunotherapy for the plasmin-positive cancers that have been difficult to treat." Researchers are now exploring clinical strategies to apply these findings. Trials investigating the use of plasmin inhibitors in combination with CAR-T or T-cell therapies for solid tumors may be on the horizon. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about science? Let us know via health@ Reference Chen, G., Tat, T., Zhou, Y., Duan, Z., Zhang, J., Scott, K., Zhao, X., Liu, Z., Wang, W., Li, S., Cross, K. A., & Chen, J. (2025). Neural network-assisted personalized handwriting analysis for Parkinson's disease diagnostics. Nature Chemical Engineering, 2(6), 358–368.
